Mediclinic Vergelegen presented the opening of its newly constructed Electrophysiology (EP) Lab, marking a significant expansion of the hospital’s cardiac services. This cutting-edge facility, which has been a long-time goal for the hospital team, represents a major step forward in providing comprehensive, world-class care to patients with heart rhythm disorders.
“The strong demand for cardiac care from our community was the catalyst for upgrading our facilities to accommodate the new unit, which required extensive investment,” explains General Manager Marquin Crotz. “Our advanced EP Unit has been designed to assist in diagnosing and treating heart rhythm disorders (arrhythmias). It is staffed by a team of cardiologists with expertise in electrophysiology, together with experienced nurses, and technicians, making this essential care easily accessible to our community.”
The EP Lab will now complement and enhance the Somerset West hospital’s existing cardiac offerings, allowing the diagnosis and treatment of a wide range of complex arrhythmias with greater precision and efficiency for both paediatric and adult patients. Equipped with the latest technology, the EP Lab will enable expert cardiologists and electrophysiologists to perform minimally invasive procedures, including ablations, device implantations and advanced diagnostic studies, all in a patient-centred environment.
“The facility will feature cutting-edge technology and a team of multidisciplinary professionals,” said Dr Adele Greyling, paediatric cardiologist and paediatric and adult electrophysiologist, “while ensuring both children and adults receive the highest standard of care in a welcoming, compassionate and patient-focused environment. With advanced diagnostic tools and customised care plans we are poised to improve the health and well-being of our community members, regardless of age.”
In addition to the new EP Lab, the existing Cathlab upgrades are also nearing completion, including the latest technology and infrastructure to enhance the structural heart intervention service offering for patients further.
“As Mediclinic Vergelegen continues to grow and evolve,” said Crotz, “we are excited about the possibilities this new cardiac unit brings, not only in terms of advancing the care we provide but also in enhancing the overall patient experience. Our team is committed to staying at the forefront of cardiac innovation to ensure that our patients have access to the best care possible.”
Mediclinic Vergelegen is dedicated to advancing cardiac care and ensuring the highest standards of patient well-being at every stage of life.
